Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Greenwich LifeSciences (GLSI) Beginning Cash Balance (2021 - 2022)

Greenwich LifeSciences filings provide 2 years of Beginning Cash Balance readings, the most recent being $2.0 million for Q2 2022.

  • Quarterly Beginning Cash Balance rose 1585.42% to $2.0 million in Q2 2022 from the year-ago period, while the trailing twelve-month figure was $7.7 million through Jun 2022, changed N/A year-over-year, with the annual reading at $360000.0 for FY2020, N/A changed from the prior year.
  • Beginning Cash Balance hit $2.0 million in Q2 2022 for Greenwich LifeSciences, down from $5.5 million in the prior quarter.
  • Across five years, Beginning Cash Balance topped out at $5.5 million in Q1 2022 and bottomed at $120000.0 in Q2 2021.